A CASE REPORT ON STAGE IV HODGKIN'S LYMPHOMA

Hodgkin's lymphoma (HL) is a type of cancer in young adults,characterized by a large inflammatory microenvironment and a low number of malignant cells originating from B lymphocytes. It is a distinct lymphomatous cancer that is histologically defined by Reed-Sternberg cells in the right kind of cell environment.The disease primarily affects young adults, with a peak incidence occurring between the ages of 15 and 35. There are two subtypes: classical Hodgkin lymphoma (CHL) and nodular lymphocyte predominant HL (NLPHL). A 75-year-old patient with Stage IV HL was admitted for chemotherapy cycle IA (75% dose) on 14/06/2023 and was prescribed medications such as Adriamycin, Vinblastine, and Dacarbazine. The patient had systemic hypertension, a cataract, and a hernia. The patient also had a history of loss of appetite, neck swelling, and difficulty in hearing.A biopsy from level III right neck showed Hodgkin's lymphoma (Lymphocyte rich CHL).The next cycle of chemotherapy was scheduled on 28/06/2023.The patient was also admitted for cycle IIA chemotherapy (75% dose) and was prescribed the same medications again.The next cycle was scheduled on 26/07/2023.